$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Alzheimer’s disease is associated with prostate cancer: a population-based study 원문보기

Oncotarget, v.9 no.7, 2018년, pp.7616 - 7622  

Lin, Herng-Ching (School of Health Care Administration, Taipei Medical University, Taipei, Taiwan) ,  Kao, Li-Ting (Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan) ,  Chung, Shiu-Dong (Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, Banciao, New Taipei City, Taiwan) ,  Huang, Chung-Chien (School of Health Care Administration, Taipei Medical University, Taipei, Taiwan) ,  Shia, Ben-Chang (Big Data Research Center, Taipei Medical University, Taipei, Taiwan) ,  Huang, Chao-Yuan (Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan)

Abstract AI-Helper 아이콘AI-Helper

Alzheimer’s disease and cancer are increasingly prevalent with advancing age. However, the association between Alzheimer’s disease and prostate cancer remains unclear. The aim of this study was to examine the relationship between prior Alzheimer’s disease and subsequent prostate cancer using a popul...

주제어

참고문헌 (39)

  1. 1 Alzheimer’s Association 2016 Alzheimer’s Disease facts and figures Alzheimers Dement 2016 12 459 509 27570871 

  2. 2 Jhan JH Yang YH Chang YH Guu SJ Tsai CC Hormone therapy for Prostate Cancer increases the risk of Alzheimer’s Disease: a nationwide 4-year longitudinal cohort study Aging Male 2017 20 33 38 28067607 

  3. 3 Brookmeyer R Johnson E Ziegler-Graham K Arrighi HM Forecasting the global burden of Alzheimer’s disease Alzheimers Dement 2007 3 186 191 19595937 

  4. 4 Plassman BL Langa KM Fisher GG Heeringa SG Weir DR Ofstedal MB Burke JR Hurd MD Potter GG Rodgers WL Steffens DC Willis RJ Wallace RB Prevalence of dementia in the United States: the aging, demographics, and memory study Neuroepidemiology 2007 29 125 132 17975326 

  5. 5 Raji MA Kuo YF Freeman JL Goodwin JS Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or Prostate Cancer: implications for cancer care Arch Intern Med 2008 168 2033 2040 18852406 

  6. 6 Bolla M Collette L Blank L Warde P Dubois JB Mirimanoff RO Storme G Bernier J Kuten A Sternberg C Mattelaer J Lopez Torecilla J Pfeffer JR Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 2002 360 103 106 12126818 

  7. 7 Pagliarulo V Bracarda S Eisenberger MA Mottet N Schröder FH Sternberg CN Studer UE Contemporary role of androgen deprivation therapy for prostate cancer Eur Urol 2012 61 11 25 21871711 

  8. 8 Lin HL Lin HC Tseng YF Chen SC Hsu CY Inverse Association Between Cancer and Dementia: A Population-based Registry Study in Taiwan Alzheimer Dis Assoc Disord 2016 30 118 22 26523711 

  9. 9 Nead KT Gaskin G Chester C Swisher-McClure S Dudley JT Leeper NJ Shah NH Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk J Clin Oncol 2016 34 566 571 26644522 

  10. 10 Nead KT Gaskin G Chester C Swisher-McClure S Leeper NJ Shah NH Association Between Androgen Deprivation Therapy and Risk of Dementia JAMA Oncol 2017 3 49 55 27737437 

  11. 11 Chung SD Lin HC Tsai MC Kao LT Huang CY Chen KC Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with Prostate Cancer Andrology 2016 4 481 485 27062333 

  12. 12 Kao LT Lin HC Chung SD Huang CY No increased risk of dementia in patients receiving androgen deprivation therapy for Prostate Cancer: a 5-year follow-up study Asian J Androl. Asian J Androl 2017 19 414 417 27232853 

  13. 13 Nead KT Sinha S Nguyen PL Prostate Cancer Androgen deprivation therapy for Prostate Cancer and dementia risk: a systematic review and meta-analysis Prostatic Dis 2017 

  14. 14 Allott EH Masko EM Freedland SJ Obesity and prostate cancer: weighing the evidence Eur Urol 2013 63 800 809 23219374 

  15. 15 Blanc-Lapierre A Spence A Karakiewicz PI Aprikian A Saad F Parent ME Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada BMC Public Health 2015 15 913 26385727 

  16. 16 Boehm K Valdivieso R Meskawi M Larcher A Schiffmann J Sun M Graefen M Saad F Parent ME Karakiewicz PI Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study World J Urol 2016 34 425 430 26108732 

  17. 17 Dennis LK Dawson DV Meta-analysis of measures of sexual activity and prostate cancer Epidemiology 2002 13 72 79 11805589 

  18. 18 Dennis LK Lynch CF Torner JC Epidemiologic association between prostatitis and prostate cancer Urology 2002 60 78 83 

  19. 19 Zhao J Stockwell T Roemer A Chikritzhs T Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis BMC Cancer 2016 16 845 27842506 

  20. 20 Ballard C Gauthier S Corbett A Brayne C Aarsland D Jones E Alzheimer’s disease Lancet 2011 377 1019 1031 21371747 

  21. 21 Scheltens P Blennow K Breteler MM de Strooper B Frisoni GB Salloway S Van der Flier WM Alzheimer's disease Lancet 2016 388 505 517 26921134 

  22. 22 Graham WV Bonito-Oliva A Sakmar TP Update on Alzheimer's Disease Therapy and Prevention Strategies Annu Rev Med 2017 68 413 430 28099083 

  23. 23 Kryscio RJ Abner EL Caban-Holt A Lovell M Goodman P Darke AK Yee M Crowley J Schmitt FA Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE) JAMA Neurol 2017 74 567 573 28319243 

  24. 24 Lee JH Kang M Wang H Naik G Mobley JA Sonpavde G Garvey WT Darley-Usmar VM Ponnazhagan S Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress FASEB J 2017 31 1608 1619 28069826 

  25. 25 Mattson MP Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives Physiol Rev 1997 77 1081 1132 9354812 

  26. 26 Hansel DE Rahman A Wehner S Herzog V Yeo CJ Maitra A Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation Cancer Res 2003 63 7032 7037 14612490 

  27. 27 Miyazaki T Ikeda K Horie-Inoue K Inoue S Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells Biochem Biophys Res Commun 2014 452 828 833 25218471 

  28. 28 Takayama K Tsutsumi S Suzuki T Horie-Inoue K Ikeda K Kaneshiro K Fujimura T Kumagai J Urano T Sakaki Y Shirahige K Sasano H Takahashi S Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth Cancer Res 2009 69 137 42 19117996 

  29. 29 Viña J Lloret A Ortí R Alonso D Molecular bases of the treatment of Alzheimer’s disease with antioxidants: prevention of oxidative stress Mol Aspects Med 2004 25 117 123 15051321 

  30. 30 Sano M Ernesto C Thomas RG Klauber MR Schafer K Grundman M Woodbury P Growdon J Cotman CW Pfeiffer E Schneider LS Thal LJ A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study N Engl J Med 1997 336 1216 1222 9110909 

  31. 31 Shiota M Yokomizo A Naito S Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer Endocr Relat Cancer 2012 19 R243 R253 23033314 

  32. 32 Ripple MO Henry WF Rago RP Wilding G Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells J Natl Cancer Inst 1997 89 40 48 8978405 

  33. 33 Trinh NH Hoblyn J Mohanty S Yaffe K Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis Jama 2003 289 210 216 12517232 

  34. 34 Xi HJ Wu RP Liu JJ Zhang LJ Li ZS Role of acetylcholinesterase in lung cancer Thorac Cancer 2015 6 390 398 26273392 

  35. 35 Ruiz-Espejo F Cabezas-Herrera J Illana J Campoy FJ Munoz-Delgado E Vidal CJ Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes Breast Cancer Res Treat 2003 80 105 114 12889604 

  36. 36 Snowden JS Thompson JC Stopford CL Richardson AM Gerhard A Neary D Mann DM The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinico-pathological relationships Brain 2011 134 2478 2492 21840888 

  37. 37 Beach TG Monsell SE Phillips LE Kukull W Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 J Neuropathol Exp Neurol 2012 71 266 273 22437338 

  38. 38 Durazzo TC Mattsson N Weiner MW Alzheimer's Disease Neuroimaging Initiative Smoking and increased Alzheimer's disease risk: a review of potential mechanisms Alzheimers Dement 2014 10 S122 S145 24924665 

  39. 39 Heneka MT Carson MJ El Khoury J Landreth GE Brosseron F Feinstein DL Jacobs AH Wyss-Coray T Vitorica J Ransohoff RM Herrup K Frautschy SA Finsen B Neuroinflammation in Alzheimer's disease Lancet Neurol 2015 14 388 405 25792098 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로